Friday, April 12, 2013 10:43:21 AM
Blade
1) Yes, I was very pleasantly surprised. I don't know whether this is a new trend or just an exception--I hope for the former. Laughren retired this past December. I had the opportunity to talk with him at length a couple weeks ago at a meeting: Very decent and knowledgeable guy. no agenda other than doing the right thing, but rather conservative and narrow in his view of how to get there. It wouldnt take much to be more flexible.
2) I have a good friend whose firm owns a lot of ACAD--He would say it is not yet fully valued, based on the current market cap against likely peak sales of pimavanserin for PD, AD, sz.
3) Back in December I met with a pharma regarding licensing opportunities. Acadia had just released its data and the price had risen, but I told them that it pimavanserin should be a priority target for a partnership. They complained that the price had just gone up. Well, it just got a lot more expensive. And Uli Hacksell is hardly an impulsive CEO, he doesnt have to move quickly. Given that most large pharmas continue to lowball their CNS partnering offers, I'm not expecting imminent news. But then again, someone could decide to wrap this up next week, making Acadia an offer they can't refuse. It would surprise me though.
Congratulations on holding ACAD longterm.
NP
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM